Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection
(Q37386747)
scientific article published on February 2009
scientific article published on February 2009
Language:
Current Data About
Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection
| (P31) |
(Q13442814)
|
||||||||||||||||||||
| (P50) |
(Q1564831)
(Q88161344)
|
||||||||||||||||||||
| (P304) |
181-189
|
||||||||||||||||||||
| (P433) |
2
|
||||||||||||||||||||
| (P478) |
10
|
||||||||||||||||||||
| (P577) |
Sunday, February 1, 2009
|
||||||||||||||||||||
| (P921) |
(Q708693)
(Q154869)
|
||||||||||||||||||||
| (P1433) |
(Q15724634)
|
||||||||||||||||||||
| (P1476) |
"Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection" (language: en)
|
||||||||||||||||||||
| (P2093) |
Ingmar Mederacke
|
||||||||||||||||||||
| (P13046) |
(Q7318358)
|